Vanda Pharmaceuticals | VNDA - هزینه های فروش





هزینه های فروش تغییر دادن تاریخ
Acadia Pharmaceuticals USD 26.22M 4.58M 2025-12
Agios Pharmaceuticals USD 1.88M 199K 2025-12
Akebia Therapeutics USD 8.13M 2.41M 2025-03
Alnylam Pharmaceuticals USD 267.72M 67.57M 2025-12
Anika Therapeutics USD 11.49M 35.48M 2025-03
AstraZeneca USD 3.27B 471M 2025-12
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
Esperion Therapeutics USD 51.63M 22.2M 2024-09
Halozyme Therapeutics USD 102.15M 29.14M 2025-12
Heron Therapeutics USD 9.46M 1.61M 2024-09
Insmed USD 46.16M 15.25M 2025-12
J&J USD 7.97B 689M 2025-12
Lexicon Pharmaceuticals USD 17.81M 3.41M 2024-06
Ligand Pharmaceuticals USD 11.9M 733K 2025-09
Merck USD 3.32B 531M 2025-12
Minerva Neurosciences 386K 31K 2024-06
Moderna USD 452M 245M 2025-12
Novartis USD 3.54B 216M 2025-09
Pfizer USD 6.29B 2.12B 2025-12
PTC Therapeutics USD 16.3M 7.02M 2025-12
Puma Biotechnology USD 29.1M 18.44M 2024-09
Sangamo BioSciences 2.42M 1.11M 2024-06
Sanofi EUR 4.29B 421M 2025-12
Takeda JPY 401.15B 184.07B 2025-12
Teva Pharmaceutical Industries USD 2.06B 120M 2025-12
Ultragenyx Pharmaceutical USD 29M 1.01M 2025-12
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12
Veracyte USD 39.28M 1.93M 2025-12